SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-040712
Filing Date
2017-06-19
Accepted
2017-06-19 07:37:53
Documents
2
Period of Report
2017-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5157
2 POA DOCUMENT poa.txt EX-24.3_732075 4161
  Complete submission text file 0001209191-17-040712.txt   10788
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Issuer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONCERT PHARMACEUTICALS INC. 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address
Lynch Ryan (Reporting) CIK: 0001709271 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36310 | Film No.: 17917494